• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Wasting away: How to treat cachexia and muscle wasting in chronic disease?

作者信息

von Haehling Stephan

机构信息

Department of Cardiology and Pneumology, University of Göttingen Medical Center, Georg-August-University, Göttingen, Germany.

DZHK (German Centre for Cardiovascular Research), Partner Site Göttingen, Germany.

出版信息

Br J Clin Pharmacol. 2017 Dec;83(12):2599-2601. doi: 10.1111/bcp.13387. Epub 2017 Aug 24.

DOI:10.1111/bcp.13387
PMID:28755533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5698575/
Abstract
摘要

相似文献

1
Wasting away: How to treat cachexia and muscle wasting in chronic disease?日渐消瘦：如何治疗慢性病中的恶病质和肌肉萎缩？
Br J Clin Pharmacol. 2017 Dec;83(12):2599-2601. doi: 10.1111/bcp.13387. Epub 2017 Aug 24.
2
MEF2c-Dependent Downregulation of Myocilin Mediates Cancer-Induced Muscle Wasting and Associates with Cachexia in Patients with Cancer.MEF2c 依赖性下调肌球蛋白调节轻链介导癌症诱导的肌肉减少症，并与癌症患者恶病质相关。
Cancer Res. 2020 May 1;80(9):1861-1874. doi: 10.1158/0008-5472.CAN-19-1558. Epub 2020 Mar 4.
3
Muscle wasting: is mitochondrial dysfunction a key target?肌肉萎缩：线粒体功能障碍是关键靶点吗？
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):213-4. doi: 10.1097/MCO.0000000000000174.
4
Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.癌症相关肌肉萎缩中的线粒体可塑性：其管理的潜在方法
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):226-33. doi: 10.1097/MCO.0000000000000161.
5
Autophagy Exacerbates Muscle Wasting in Cancer Cachexia and Impairs Mitochondrial Function.自噬加剧癌症恶病质中的肌肉消耗，并损害线粒体功能。
J Mol Biol. 2019 Jul 12;431(15):2674-2686. doi: 10.1016/j.jmb.2019.05.032. Epub 2019 May 28.
6
Mechanisms to explain wasting of muscle and fat in cancer cachexia.解释癌症恶病质中肌肉和脂肪消耗的机制。
Curr Opin Support Palliat Care. 2007 Dec;1(4):293-8. doi: 10.1097/SPC.0b013e3282f34738.
7
Muscle wasting in cardiac cachexia.心脏恶病质中的肌肉萎缩。
Int J Biochem Cell Biol. 2005 Oct;37(10):1938-47. doi: 10.1016/j.biocel.2005.03.013.
8
Muscle wasting in cancer: the role of mitochondria.癌症中的肌肉萎缩：线粒体的作用。
Curr Opin Clin Nutr Metab Care. 2015 May;18(3):221-5. doi: 10.1097/MCO.0000000000000164.
9
Beta-hydroxy-beta-methylbutyrate supplementation and skeletal muscle in healthy and muscle-wasting conditions.在健康及肌肉萎缩状态下补充β-羟基-β-甲基丁酸与骨骼肌的关系
J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):529-541. doi: 10.1002/jcsm.12208. Epub 2017 May 10.
10
Mechanism and novel therapeutic approaches to wasting in chronic disease.慢性疾病消耗的发生机制和新的治疗方法。
Maturitas. 2013 Jul;75(3):199-206. doi: 10.1016/j.maturitas.2013.03.014. Epub 2013 May 9.

引用本文的文献

1
Episodic Binge-like Ethanol Reduces Skeletal Muscle Strength Associated with Atrophy, Fibrosis, and Inflammation in Young Rats.间歇性 binge 样乙醇摄入降低年轻大鼠骨骼肌力量与萎缩、纤维化和炎症相关。
Int J Mol Sci. 2023 Jan 14;24(2):1655. doi: 10.3390/ijms24021655.

本文引用的文献

1
Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women.选择性雄激素受体调节剂 GSK2881078 在健康男性和绝经后女性中的安全性、药代动力学和药效学。
Br J Clin Pharmacol. 2017 Oct;83(10):2179-2194. doi: 10.1111/bcp.13316. Epub 2017 Jun 10.
2
Muscle wasting and cachexia in heart failure: mechanisms and therapies.心力衰竭中的肌肉减少症和恶病质：机制和治疗方法。
Nat Rev Cardiol. 2017 Jun;14(6):323-341. doi: 10.1038/nrcardio.2017.51. Epub 2017 Apr 24.
3
The Evolving Approach to Management of Cancer Cachexia.癌症恶病质管理的不断演进方法
Oncology (Williston Park). 2017 Jan 15;31(1):23-32.
4
A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project.一项关于维生素、矿物质、蛋白质和其他补充剂在癌症恶病质治疗中的作用的系统评价：欧洲姑息治疗研究中心恶病质项目。
J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):25-39. doi: 10.1002/jcsm.12127. Epub 2016 Jul 20.
5
Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016.欧洲、美国和日本慢性疾病恶病质的流行情况及其对临床的影响：2016 年的事实和数据更新。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):507-509. doi: 10.1002/jcsm.12167. Epub 2016 Nov 2.
6
Association of estimated glomerular filtration rate with all-cause and cardiovascular mortality: the role of malnutrition-inflammation-cachexia syndrome.估算肾小球滤过率与全因死亡率和心血管死亡率的关联：营养不良-炎症-恶病质综合征的作用
J Cachexia Sarcopenia Muscle. 2016 May;7(2):144-51. doi: 10.1002/jcsm.12053. Epub 2016 Jan 5.
7
Study Design and Rationale for the Phase 3 Clinical Development Program of Enobosarm, a Selective Androgen Receptor Modulator, for the Prevention and Treatment of Muscle Wasting in Cancer Patients (POWER Trials).选择性雄激素受体调节剂恩杂鲁胺用于预防和治疗癌症患者肌肉萎缩的3期临床开发项目（POWER试验）的研究设计与原理
Curr Oncol Rep. 2016 Jun;18(6):37. doi: 10.1007/s11912-016-0522-0.
8
Reference ranges of handgrip strength from 125,462 healthy adults in 21 countries: a prospective urban rural epidemiologic (PURE) study.21 个国家/地区 125462 名健康成年人的握力参考范围：一项前瞻性城乡流行病学（PURE）研究。
J Cachexia Sarcopenia Muscle. 2016 Dec;7(5):535-546. doi: 10.1002/jcsm.12112. Epub 2016 Apr 12.
9
SARC-F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes.SARC - F：一种用于预测有肌肉减少症风险且功能预后较差人群的症状评分。
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):28-36. doi: 10.1002/jcsm.12048. Epub 2015 Jul 7.
10
Cachexia in chronic obstructive pulmonary disease: new insights and therapeutic perspective.慢性阻塞性肺疾病中的恶病质：新见解与治疗前景
J Cachexia Sarcopenia Muscle. 2016 Mar;7(1):5-22. doi: 10.1002/jcsm.12062. Epub 2015 Sep 7.